Choose Life Biotech SA (CLB) is an independent and innovative start-up based in Bellinzona (Switzerland) that operates in the nanobodies sector. CLB aims to be a highly specialized biotech company focused on research and development using proprietary and exclusive libraries of rationally engineered nanobodies either as carriers of active payloads or active ingredients themselves. Our Mission is pre-clinical R&D through state of the art antibody discovery and development, expanding the R&D pipelines of partnering Pharma Companies with nanobodies libraries specifically tailored to their selected targets. CLB is founded and staffed by highly qualified scientists with accrued expertise in world renown centers of excellence including Cambridge, Stanford and ETH Zurich, supported by a managerial Team with decades of world-wide experience. CLB has cutting edge technologies in house and access to extensive facilities through collaboration to the thriving Bellinzona academic and biotech environment. Our Vision is to become leaders in the research and development of engineered nanobody libraries.
